Baseline scores, mean change, standardized mean change, and sample sizes for all studies reporting change on the Hamilton Rating Scale for Depression.

“Approval” column designates whether the study was submitted as part of the original approval submission to the FDA or whether it was conducted following FDA approval in 1991 or later. Drug benefit denotes the effect size for paroxetine compared to placebo.
Baseline scores, mean change, standardized mean change, and sample sizes for all studies reporting change on the Hamilton Rating Scale for Depression.

“审批”（Approval）列用于标识各研究是作为向美国食品药品监督管理局（Food and Drug Administration, FDA）提交的原始审批申报资料的组成部分，还是在1991年或之后获得FDA审批后开展的研究。“药物获益”（Drug benefit）指标代表帕罗西汀相较于安慰剂的效应量。本数据集涵盖所有报告了汉密尔顿抑郁评定量表（Hamilton Rating Scale for Depression）得分变化情况的研究的基线评分、平均变化值、标准化平均变化值及样本量。